New-onset atrial fibrillation and thromboembolic risk: Cardiovascular syzygy?

Simple item page
dc.contributor.authorProcter, N.
dc.contributor.authorStewart, S.
dc.contributor.authorHorowitz, J.
dc.date.issued2016
dc.description.abstractAbstract not available
dc.description.statementofresponsibilityNathan E.K.Procter, Simon Stewart, John D.Horowitz
dc.identifier.citationHeart Rhythm, 2016; 13(6):1355-1361
dc.identifier.doi10.1016/j.hrthm.2015.12.010
dc.identifier.issn1547-5271
dc.identifier.issn1556-3871
dc.identifier.orcidStewart, S. [0000-0001-9032-8998]
dc.identifier.orcidHorowitz, J. [0000-0001-6883-0703]
dc.identifier.urihttp://hdl.handle.net/2440/100466
dc.language.isoen
dc.publisherElsevier Science
dc.relation.grantNHMRC
dc.rights© 2016 Heart Rhythm Society.All rights reserved.
dc.source.urihttps://doi.org/10.1016/j.hrthm.2015.12.010
dc.subjectAtrial fibrillation
dc.subjectnew onset
dc.subjectthromboembolism
dc.subjectanticoagulation
dc.subjectVirchow
dc.titleNew-onset atrial fibrillation and thromboembolic risk: Cardiovascular syzygy?
dc.typeJournal article
pubs.publication-statusPublished

Files

Collections

Medicine publications